相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A TrkB Small Molecule Partial Agonist Rescues TrkB Phosphorylation Deficits and Improves Respiratory Function in a Mouse Model of Rett Syndrome
Danielle A. Schmid et al.
JOURNAL OF NEUROSCIENCE (2012)
Niacin and Statin Combination Therapy for Atherosclerosis Regression and Prevention of Cardiovascular Disease Events Reconciling the AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides: Impact on Global Health Outcomes) Trial With Previous Surrogate Endpoint Trials
Erin D. Michos et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
The role of BDNF in depression on the basis of its location in the neural circuitry
Hui Yu et al.
ACTA PHARMACOLOGICA SINICA (2011)
Current and Emerging Drug Treatment Options for Alzheimerʼs Disease
Nathan Herrmann et al.
DRUGS (2011)
Evidence for GABAergic inhibitory deficits in major depressive disorder
Paul E. Croarkin et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2011)
Genetically engineered mesenchymal stem cells reduce behavioral deficits in the YAC 128 mouse model of Huntington's disease
Nicholas D. Dey et al.
BEHAVIOURAL BRAIN RESEARCH (2010)
Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents
Stephen M. Massa et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Eight Years of Clinical Improvement in MPTP-Lesioned Primates After Gene Therapy With AAV2-hAADC
Piotr Hadaczek et al.
MOLECULAR THERAPY (2010)
Current view of glucocorticoid co-therapy with DMARDs in rheumatoid arthritis
Jos N. Hoes et al.
NATURE REVIEWS RHEUMATOLOGY (2010)
Modulation of γ-Secretase Reduces β-Amyloid Deposition in a Transgenic Mouse Model of Alzheimer's Disease
Maria Z. Kounnas et al.
NEURON (2010)
Excitatory-Inhibitory Relationship in the Fascia Dentata in the Ts65Dn Mouse Model of Down Syndrome
Pavel V. Belichenko et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2009)
Molecular therapy of obesity and diabetes by a physiological autoregulatory approach
Lei Cao et al.
NATURE MEDICINE (2009)
Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease
Alan H. Nagahara et al.
NATURE MEDICINE (2009)
Safety and tolerability of putaminal AADC gene therapy for Parkinson disease
C. W. Christine et al.
NEUROLOGY (2009)
EXPRESSION, BIOACTIVITY, AND SAFETY 1 YEAR AFTER ADENO-ASSOCIATED VIRAL VECTOR TYPE 2-MEDIATED DELIVERY OF NEURTURIN TO THE MONKEY NIGROSTRIATAL SYSTEM SUPPORT CERE-120 FOR PARKINSON'S DISEASE
Christopher D. Herzo et al.
NEUROSURGERY (2009)
Treatment of late infantile neuronal ceroid lipofuscinosis by CNS administration of a serotype 2 adeno-associated virus expressing CLN2 cDNA
Stefan Worgall et al.
HUMAN GENE THERAPY (2008)
Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial
William J. Marks et al.
LANCET NEUROLOGY (2008)
Low-dose glucocorticoid therapy decreases risk for treatment-limiting infusion reaction to infliximab in patients with rheumatoid arthritis
Jenny Augustsson et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Expression profiling of Huntington's disease models suggests that brain-derived neurotrophic factor depletion plays a major role in striatal degeneration
Andrew D. Strand et al.
JOURNAL OF NEUROSCIENCE (2007)
Transient growth factor delivery sustains regenerated axons after spinal cord injury
Armin Blesch et al.
JOURNAL OF NEUROSCIENCE (2007)
Advances in small molecules promoting neurotrophic function
Raymond D. Price et al.
PHARMACOLOGY & THERAPEUTICS (2007)
Comparative effects on lipid levels of combination therapy with a statin and extended-release niacin or ezetimibe versus a statin alone (the COMPELL study)
James M. McKenney et al.
ATHEROSCLEROSIS (2007)
Striatal delivery of neurturin by CERE-120, an AAV2 vector for the treatment of dopaminergic neuron degeneration in Parkinson's disease
Mehdi Gasmi et al.
MOLECULAR THERAPY (2007)
Six-month continuous intraputamenal infusion toxicity study of recombinant methionyl human glial cell line-derived neurotrophic factor (r-metHuGDNF) in rhesus monkeys
David N. Hovland et al.
TOXICOLOGIC PATHOLOGY (2007)
Long-term clinical improvement in MPTP-lesioned primates after gene therapy with AAV-hAADC
Krystof S. Bankiewicz et al.
MOLECULAR THERAPY (2006)
The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment - Results of a phase IIb randomized, double-blind, placebo-controlled, dose-ranging trial
P Emery et al.
ARTHRITIS AND RHEUMATISM (2006)
Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease
AE Lang et al.
ANNALS OF NEUROLOGY (2006)
An epidemiological study of motor neuron disease in Hong Kong
GCY Fong et al.
AMYOTROPHIC LATERAL SCLEROSIS (2005)
Regulated lentiviral NGF gene transfer controls rescue of medial septal cholinergic neurons
A Blesch et al.
MOLECULAR THERAPY (2005)
Autonomic dysfunction in ALS: A preliminary study on the effects of intrathecal BDNF
M Beck et al.
AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS (2005)
A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease
MH Tuszynski et al.
NATURE MEDICINE (2005)
Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules
LR Gauthier et al.
CELL (2004)
Design of potent peptide mimetics of brain-derived neurotrophic factor
PD O'Leary et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
NGF signaling in sensory neurons: Evidence that early endosomes carry NGF retrograde signals
JD Delcroix et al.
NEURON (2003)
Neurotrophins and their receptors: A convergence point for many signalling pathways
MV Chao
NATURE REVIEWS NEUROSCIENCE (2003)
Converting a peptide into a drug: Strategies to improve stability and bioavailability
C Adessi et al.
CURRENT MEDICINAL CHEMISTRY (2002)
NGF signaling from clathrin-coated vesicles: Evidence that signaling endosomes serve as a platform for the Ras-MAPK pathway
CL Howe et al.
NEURON (2001)
Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses
N Durany et al.
SCHIZOPHRENIA RESEARCH (2001)
Failed retrograde transport of NGF in a mouse model of Down's syndrome: Reversal of cholinergic neurodegenerative phenotypes following NGF infusion
JD Cooper et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Pegylated brain-derived neurotrophic factor shows improved distribution into the spinal cord and stimulates locomotor activity and morphological changes after injury
DP Ankeny et al.
EXPERIMENTAL NEUROLOGY (2001)
Nontropic actions of neurotrophins: Subcortical nerve growth factor gene delivery reverses age-related degeneration of primate cortical cholinergic innervation
JM Conner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy - A randomized controled trial
SC Apfel et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease
JH Kordower et al.
SCIENCE (2000)
Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice
S Capsoni et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
A phase I/II trial of recombinant methionyl human brain derived neurotrophic factor administered by intrathecal infusion to patients with amyotrophic lateral sclerosis
G Ochs et al.
AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS (2000)
分享论文
